Prolaio
About Prolaio
Prolaio is a clinical intelligence company that leverages advanced data science and artificial intelligence to revolutionize cardiovascular care and research. The company’s platform integrates a connected system powered by real-world patient data, enabling personalized care plans and improved outcomes for individuals with heart conditions. Prolaio’s FDA-cleared software and proprietary algorithms are designed to collect continuous, high-density cardiovascular data from wearable biosensors, translating this information into actionable insights for clinicians and researchers.
For physicians, Prolaio’s technology offers a means to move beyond episodic data, providing a more comprehensive and continuous understanding of a patient’s heart health. This approach supports early intervention points, evidence-based care plans, and the proactive management of conditions like heart failure. The platform also plays a crucial role in clinical research and drug development by optimizing study design, increasing statistical power, and enhancing confidence through better data, ultimately aiming to accelerate therapeutic discovery and deliver precision cardiovascular care.
Founded by experts in cardiovascular medicine and data science, Prolaio is committed to addressing cardiovascular disease, the leading cause of death worldwide, by transforming real-world heart data into faster discovery and precision care. The company’s innovative approach focuses on patient-centered, science-driven solutions, utilizing digital biomarkers to predict physiological changes and empower more timely and effective interventions.
Focus Areas
Business Intelligence
| Partnerships | Kardigan (acquisition), physIQ (acquisition by Prolaio) |
| Acquisitions | Acquired by Kardigan (March 27, 2025); Acquired physIQ |
| Technology | Cloud-native platform leveraging advanced data science, proprietary algorithms, and real-world patient data. Utilizes AWS, Amazon S3, and Amazon CloudFront. Focuses on digital biomarkers and continuous physiological data streams from wearable biosensors. |
| FDA Clearances | 5 cleared products (estimated) |
What Physicians Need to Know
For physicians, Prolaio offers unparalleled data-driven insights, enabling more informed clinical decisions and the ability to personalize treatment plans based on continuous, real-world patient data. The platform facilitates early detection and timely intervention, potentially reducing hospitalizations and emergency visits, especially for conditions like heart failure and HCM. Its FDA-cleared and rigorously validated technology builds trust, while the integrated approach simplifies workflows and enhances patient engagement through remote monitoring and communication tools. This allows for a more proactive and effective management of cardiovascular conditions.
Prolaio's platform is designed to integrate high-density patient data and proprietary algorithms to deliver outcome-driven insights. While specific third-party integrations are not explicitly detailed beyond their own comprehensive kit, their acquisition by Kardigan indicates a strategic integration into drug development pipelines. Their platform is built to unite patients, providers, and researchers, suggesting a capability for data sharing and collaboration within the healthcare ecosystem.
What the Web Says
Prolaio is a clinical intelligence company focused on cardiovascular health, utilizing data-driven technology and FDA-cleared algorithms for remote patient monitoring, clinical research, and drug development. The company emphasizes a pioneering and collaborative culture, with employees reporting high satisfaction due to a shared mission and supportive environment. Prolaio was recently acquired by Kardigan, which is seen as an opportunity to amplify its impact in cardiovascular care.
Overall: PositiveStrengths
- Pioneering and innovative company culture focused on cardiovascular care.
- Collaborative and supportive work environment with responsive colleagues.
- Meaningful work that aims to improve patient outcomes and advance clinical goals.
- Strong focus on scientific rigor and building FDA-cleared, clinically credible technology.
- Offers competitive compensation, comprehensive health benefits, and flexible/hybrid work options.
- User-centered design approach for product development, leading to effective tools.
Limitations
- No specific product or employer cons were found across the searched platforms for Prolaio.
- Some general concerns about privacy are sometimes raised with proctoring software, but this is not specific to Prolaio.
- One review for a different company with a similar name mentioned inconsistent work and low pay, but this is not Prolaio.
Based on reviews from: Built In, G2, Capterra, ZipRecruiter, Indeed.com, SimplyHired
Last updated: 2026-07-19
Videos
News, demos, and interviews about Prolaio.
Videos load interactively. If none appear, search YouTube for Prolaio →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]